Viewing StudyNCT04744363



Ignite Creation Date: 2024-05-06 @ 3:45 PM
Last Modification Date: 2025-12-17 @ 7:06 AM
Study NCT ID: NCT04744363
Status: None
Last Update Posted: 2022-05-23 00:00:00
First Post: 2020-12-16 00:00:00

Brief Title: Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab)
Sponsor: Alvotech Swiss AG
Organization: Alvotech Swiss AG

Organization Data

Organization: Alvotech Swiss AG
Class: INDUSTRY
Study ID: AVT04-GL-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Alvotech Swiss AG
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Iqvia Pty Ltd INDUSTRY